Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Disc Medicine, Inc. for the registration of up to $400.0 million of its common stock, preferred stock, debt securities, warrants, and units and to the incorporation by reference therein of our report dated March 31, 2023, with respect to the consolidated financial statements of Disc Medicine, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Boston, Massachusetts
November 17, 2023